secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ensysce Biosciences, Inc. (ENSC)
CIK:        0001716947
Form:       8-K
Filed at:   2023-11-29T23:59:59+00:00
Accession:  0001493152-23-043009
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 2.03, 3.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ensysce completes $1.7M convertible note financing; second closing of $1.133M
-----------------------------------------------------------------------------

- Total gross proceeds of $1.7M from senior secured convertible notes and warrants; second closing on Nov 28/29, 2023 added $1.133M (net).
- Notes convertible at $1.5675/share, 6% interest, 6-month term; monthly redemption begins 90 days after issuance.
- Warrants to purchase up to 3.77M shares at $1.5675, exercisable for five years from issuance.
- Proceeds to fund PF614 time of onset study and regulatory milestones.
- Notes secured by all company assets and guaranteed by subsidiaries EBI OpCo and EBI.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716947/000149315223043009/0001493152-23-043009-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716947/000149315223043009/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-043009

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer